-
Multi-Modality Representation Learning for Antibody-Antigen Interactions Prediction
Authors:
Peijin Guo,
Minghui Li,
Hewen Pan,
Ruixiang Huang,
Lulu Xue,
Shengqing Hu,
Zikang Guo,
Wei Wan,
Shengshan Hu
Abstract:
While deep learning models play a crucial role in predicting antibody-antigen interactions (AAI), the scarcity of publicly available sequence-structure pairings constrains their generalization. Current AAI methods often focus on residue-level static details, overlooking fine-grained structural representations of antibodies and their inter-antibody similarities. To tackle this challenge, we introdu…
▽ More
While deep learning models play a crucial role in predicting antibody-antigen interactions (AAI), the scarcity of publicly available sequence-structure pairings constrains their generalization. Current AAI methods often focus on residue-level static details, overlooking fine-grained structural representations of antibodies and their inter-antibody similarities. To tackle this challenge, we introduce a multi-modality representation approach that integates 3D structural and 1D sequence data to unravel intricate intra-antibody hierarchical relationships. By harnessing these representations, we present MuLAAIP, an AAI prediction framework that utilizes graph attention networks to illuminate graph-level structural features and normalized adaptive graph convolution networks to capture inter-antibody sequence associations. Furthermore, we have curated an AAI benchmark dataset comprising both structural and sequence information along with interaction labels. Through extensive experiments on this benchmark, our results demonstrate that MuLAAIP outperforms current state-of-the-art methods in terms of predictive performance. The implementation code and dataset are publicly available at https://github.com/trashTian/MuLAAIP for reproducibility.
△ Less
Submitted 22 March, 2025;
originally announced March 2025.
-
Strategic priorities for transformative progress in advancing biology with proteomics and artificial intelligence
Authors:
Yingying Sun,
Jun A,
Zhiwei Liu,
Rui Sun,
Liujia Qian,
Samuel H. Payne,
Wout Bittremieux,
Markus Ralser,
Chen Li,
Yi Chen,
Zhen Dong,
Yasset Perez-Riverol,
Asif Khan,
Chris Sander,
Ruedi Aebersold,
Juan Antonio Vizcaíno,
Jonathan R Krieger,
Jianhua Yao,
Han Wen,
Linfeng Zhang,
Yunping Zhu,
Yue Xuan,
Benjamin Boyang Sun,
Liang Qiao,
Henning Hermjakob
, et al. (37 additional authors not shown)
Abstract:
Artificial intelligence (AI) is transforming scientific research, including proteomics. Advances in mass spectrometry (MS)-based proteomics data quality, diversity, and scale, combined with groundbreaking AI techniques, are unlocking new challenges and opportunities in biological discovery. Here, we highlight key areas where AI is driving innovation, from data analysis to new biological insights.…
▽ More
Artificial intelligence (AI) is transforming scientific research, including proteomics. Advances in mass spectrometry (MS)-based proteomics data quality, diversity, and scale, combined with groundbreaking AI techniques, are unlocking new challenges and opportunities in biological discovery. Here, we highlight key areas where AI is driving innovation, from data analysis to new biological insights. These include developing an AI-friendly ecosystem for proteomics data generation, sharing, and analysis; improving peptide and protein identification and quantification; characterizing protein-protein interactions and protein complexes; advancing spatial and perturbation proteomics; integrating multi-omics data; and ultimately enabling AI-empowered virtual cells.
△ Less
Submitted 21 February, 2025;
originally announced February 2025.
-
ViDTA: Enhanced Drug-Target Affinity Prediction via Virtual Graph Nodes and Attention-based Feature Fusion
Authors:
Minghui Li,
Zikang Guo,
Yang Wu,
Peijin Guo,
Yao Shi,
Shengshan Hu,
Wei Wan,
Shengqing Hu
Abstract:
Drug-target interaction is fundamental in understanding how drugs affect biological systems, and accurately predicting drug-target affinity (DTA) is vital for drug discovery. Recently, deep learning methods have emerged as a significant approach for estimating the binding strength between drugs and target proteins. However, existing methods simply utilize the drug's local information from molecula…
▽ More
Drug-target interaction is fundamental in understanding how drugs affect biological systems, and accurately predicting drug-target affinity (DTA) is vital for drug discovery. Recently, deep learning methods have emerged as a significant approach for estimating the binding strength between drugs and target proteins. However, existing methods simply utilize the drug's local information from molecular topology rather than global information. Additionally, the features of drugs and proteins are usually fused with a simple concatenation operation, limiting their effectiveness. To address these challenges, we proposed ViDTA, an enhanced DTA prediction framework. We introduce virtual nodes into the Graph Neural Network (GNN)-based drug feature extraction network, which acts as a global memory to exchange messages more efficiently. By incorporating virtual graph nodes, we seamlessly integrate local and global features of drug molecular structures, expanding the GNN's receptive field. Additionally, we propose an attention-based linear feature fusion network for better capturing the interaction information between drugs and proteins. Experimental results evaluated on various benchmarks including Davis, Metz, and KIBA demonstrate that our proposed ViDTA outperforms the state-of-the-art baselines.
△ Less
Submitted 27 December, 2024;
originally announced December 2024.
